Molly Hemmeter
Analyst · Griffin Securities. Your question please
Thanks, Greg. Over the last several months, the U.S. and Mexico have faced a series of unprecedented weather and natural disaster events. Starting in June of this year, a series of tropical storms generated high humidity and excessive moisture to several growing regions within Mexico and California, further complicated by record-breaking high temperatures. This late August, Hurricane Harvey, Hurricane Irma and most recently, Hurricane Maria, have devastated the U.S. and its territories with unprecedented winds, widespread flooding, power outage and vast damage to infrastructure. Now in addition, Mexico has suffered a series of high-magnitude earthquakes. Our thoughts and prayers go out to all those whose lives have been affected by these tragedies. I am very proud that the Landec employees who have rallied and worked as a team to donate Eat Smart fresh salads to victims of the hurricanes. Our employees are currently collecting bins of personal supplies to deliver to earthquake victims in Mexico. We are extremely thankful that no Landec facilities were damaged and most importantly, that no Landec employees were harmed. Although these extreme weather conditions did cause challenges for Apio, Apio’s supply chain, sales and customer service teams worked diligently to partner with our high-quality growers throughout U.S. and Mexico to minimize disruptions to customers. As a result of preplanning, hard work and an increasingly geographically diverse grower base, we see no significant impact on our fiscal 2018 results, and as Greg said, we are reiterating our fiscal year 2018 guidance. Let me take a step back and tell more about our rapidly evolving natural foods business. This business currently consists of Apio, our packaged fresh vegetable business; and O Olive, our all-natural and premium olive oil and wine vinegar business. The transformation of our natural food business is made up of 2 distinct phases. The first phase began in fiscal year 2015 and focused on transitioning Apio from a commodity produce company to a true innovation company that is focused on identifying consumer healthy eating trends and developing value-added products to support these trends. Last fiscal year, we advanced this effort with the reorganization of our retail sales force, the addition of a new VP of Innovation and R&D, further rightsizing of our lower-margin historical core vegetable products and the launch of our innovative single-serve salads. We plan to complete the rightsizing of our historical lower-margin business in fiscal 2018 while adding new capabilities and introducing innovative products to deliver ongoing revenue and profit growth. The second phase of the transformation of our natural foods business began in fiscal year 2017 and continues in this fiscal year. The second phase involves expanding our product line from fresh packaged vegetables to include other natural food products outside of produce that meet consumer needs from higher margins and display less volatile raw material sourcing characteristics. To initiate the second phase during last fiscal year, we launched the Eat Smart 100% Clean Label initiative to ensure that all of our Eat Smart products will be made from all-natural ingredients. We also added the Landec new ventures group to focus on our natural food product strategy and to lead new product development and acquisition initiatives in this area. The acquisition of O Olive, a supplier of natural olive oils and wine vinegars, was the – one of the initial products of this group. We intend to leverage synergies with Apio to position O Olive as the innovative leader with all-natural California-grown ingredients that are fully traceable. During fiscal 2018, we are accelerating our efforts in the second phase of Apio’s transformation, in preparation for new product launches in the natural food space targeted for fiscal 2019 and beyond. Landec finds itself in a strong position in fiscal year 2018. We are excited to begin leveraging many of the investments we have made over the past 2 years in both capital and personnel to create forward momentum. During the last 2 years, we increased capacity of both Apio and Lifecore to meet future demand, and we added senior management personnel in the areas of sales, marketing, product development and business development to implement and drive our future growth strategies. This fiscal year, we expect increasing production volumes of our higher-margin products at both Apio and Lifecore to begin filling this capacity and increasing our gross margins over time. Similar to our food business, which continues to benefit from tailwinds of positive sales momentum and healthy eating trends, Lifecore is also benefiting from growing trend among pharmaceutical and other medical material companies to outsource specialty services and manufacturing. With the growing number of products in the industry seeking FDA approval, Lifecore is well positioned as a fully integrated CDMO to augment its pipeline with new products to fuel its long-term growth. This fiscal year, Landec is focused on delivering value for today and tomorrow. We will continue to innovate. At Apio, we will launch new Eat Smart products that make it easy and delicious for consumers to eat healthy. At Lifecore, we will add new processes and capabilities to meet the needs of our customers and – that have difficult-to-handle biomaterials. We are also focused on increasing production volumes in each of our facilities to drive efficiencies and increase our return on invested capital. Finally, we are defining and implementing projects that will drive future growth. For fiscal 2018, we expect capital expenditures of $44 million to $48 million. Approximately $12 million to $15 million of this spend is allotted for typical annual maintenance capital, but the remaining capital spend is needed to support existing projects to fuel our future growth. Moving forward, we are focused on three primary growth platforms. First, in our Lifecore biomaterials business, we expect revenues to grow, on average, at low double-digit rates over the next 5 years. As part of the transition to a CDMO business, Lifecore is adding new syringe-filling capacity over the next several months and new vial-filling capacity within the next 12 months, both of which will be needed in the future to meet the demand we expect from our deep pipeline of development programs, along with continuing growth from existing customers. Second, our Eat Smart Salad products are on trend within the fast-growing healthy eating space. With continued innovation and our new sales force in place, we expect revenues in our salad business to also generate low double-digit growth on average over the next 5 years. Third, we will continue to explore expansion into higher-margin natural food products, adjacent to produce, in order to leverage Apio’s national fresh food supply chain. As a first of these endeavors, we are committed to investing in growing O Olive by leveraging the sales, customer service, and purchasing and procurement capabilities of Apio to ensure that we realize a high return on our investment. In summary, we will continue to focus on developing innovative products to deliver value to our customers, consumers and shareholders. Our balance sheet remains strong and provides the resources we need for executing on our strategic objectives and reaching our financial goals. We are now open for questions.